Small Extracellular Vesicles in Pre-Therapy Plasma Predict Clinical Outcome in Non-Small-Cell Lung Cancer Patients

SIMPLE SUMMARY: Since re-biopsy of the primary tumor or metastatic lesions is not an option in most NSCLC patients, the use of the “liquid tumor biopsy” represents a promising non-invasive diagnostic/prognostic approach. Small extracellular vesicles (sEV) are currently emerging as a promising source...

Descripción completa

Detalles Bibliográficos
Autores principales: Vetsika, Eleni-Kyriaki, Sharma, Priyanka, Samaras, Ioannis, Markou, Alexandra, Georgoulias, Vassilis, Whiteside, Theresa L., Kotsakis, Athanasios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122966/
https://www.ncbi.nlm.nih.gov/pubmed/33922569
http://dx.doi.org/10.3390/cancers13092041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122966/
https://www.ncbi.nlm.nih.gov/pubmed/33922569
http://dx.doi.org/10.3390/cancers13092041

Ejemplares similares